Form 4: General Resonance LLC Reports Minor Sale of Clene Inc. Shares

General Resonance LLC, a 10% owner and director of Clene Inc., reported the sale of 410 shares of common stock at $2.73 per share, reducing its direct beneficial ownership to 709,602 shares.

Summary

• General Resonance LLC, identified as both a Director and a 10% Owner of Clene Inc. (CLNN), filed a Form 4 with the SEC.
• The filing details a transaction involving the sale of 410 shares of Clene Inc. Common Stock.
• The transaction occurred on May 29, 2025, with the shares sold at a price of $2.73 per share.
• Following this reported transaction, General Resonance LLC directly beneficially owns 709,602 shares of Clene Inc. Common Stock.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to an insider sale, but the extremely small volume of shares sold (410 shares) relative to the total beneficial ownership (709,602 shares) significantly mitigates any strong negative implications.

Negatives

• A 10% owner and director, General Resonance LLC, disposed of 410 shares of Clene Inc. common stock, which could be perceived as a minor negative signal, although the volume is very small.

Industry Context

This document is a routine insider transaction report (Form 4) and does not provide information relevant to broader industry trends or competitive analysis beyond the specific company and its insider activity.

Stakeholder Impact

• Shareholders may perceive a slight negative signal due to the sale of shares by a 10% owner and director, although the minimal volume of shares sold is unlikely to cause significant concern.

Key Dates

Recommendation

Keywords

Clene Inc., CLNN, Form 4, insider transaction, beneficial ownership, stock sale, General Resonance LLC